Keyphrases
Immunohistochemistry
100%
Poly(ADP-ribose) Polymerase
100%
Human Tissue
100%
Blood Cells
100%
Ex Vivo Studies
100%
Human Biopsies
100%
PARP Inhibitor (PARPi)
80%
Poly(ADP-ribose)
40%
DNA Damage
20%
Inflammation
20%
Oxidative Stress
20%
Pharmacological Inhibitors
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Post-translational Modification
20%
Clinical Testing
20%
Beneficial Effects
20%
Human Use
20%
Ischemia-reperfusion Injury
20%
Nitrosative Stress
20%
Nicotinamide Adenine Dinucleotide (NAD+)
20%
Ovarian Cancer
20%
Negatively Charged
20%
Cardioprotection
20%
Circulating Leukocytes
20%
Malignant Tumor
20%
Charged Polymers
20%
PARylation
20%
Olaparib
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
40%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
40%
Malignant Neoplasm
20%
Inflammation
20%
Diabetes Mellitus
20%
Poly(adenosine Diphosphate Ribose)
20%
Reperfusion Injury
20%
Adenosine Diphosphate
20%
Ovary Cancer
20%
Olaparib
20%